The Hepatitis C Trust Patient Conference programme announced
Wed, 06/21/2017 - 14:06
Follow On Twitter
"Speak Up" on World Hepatitis Day, The Hepatitis C Trust Patient Conference
The Hepatitis C Trust is delighted to confirm the programme for this year's Patient Conference, which is being held in London on 28th July to coincide with World Hepatitis Day. Speakers will include Professor Graham Foster (Professor of Hepatology, Queen Mary University), Sam May (Head of Support Services, The Hepatitis C Trust), and Dr Magdalena Harris (Lecturer, London School of Hygiene and Tropical Medicine), and there will also be an opportunity to share personal stories about the impact of hepatitis C.
The event is free to attend for all patients and professionals and you can secure your place here.
Continue reading....
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment